Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 9 | 2017 | 329 | 0.800 |
Why?
|
| Early Detection of Cancer | 6 | 2016 | 79 | 0.770 |
Why?
|
| Mammography | 7 | 2017 | 34 | 0.740 |
Why?
|
| Practice Guidelines as Topic | 7 | 2016 | 333 | 0.690 |
Why?
|
| Radiology | 8 | 2017 | 22 | 0.640 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2016 | 184 | 0.380 |
Why?
|
| Diagnostic Imaging | 4 | 2017 | 90 | 0.370 |
Why?
|
| Neoplasm Metastasis | 3 | 2016 | 101 | 0.320 |
Why?
|
| Medical Oncology | 5 | 2016 | 32 | 0.280 |
Why?
|
| Palpation | 2 | 2016 | 4 | 0.270 |
Why?
|
| Ultrasonography, Mammary | 3 | 2017 | 8 | 0.210 |
Why?
|
| United States | 8 | 2017 | 2332 | 0.170 |
Why?
|
| Evidence-Based Medicine | 5 | 2017 | 206 | 0.170 |
Why?
|
| Mastodynia | 1 | 2017 | 1 | 0.150 |
Why?
|
| Carcinoma, Lobular | 2 | 2015 | 13 | 0.150 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 24 | 0.150 |
Why?
|
| Breast Diseases | 1 | 2015 | 6 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 553 | 0.130 |
Why?
|
| Neoplasm Staging | 4 | 2016 | 340 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2015 | 86 | 0.120 |
Why?
|
| Women's Health | 2 | 2014 | 245 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 788 | 0.120 |
Why?
|
| Breast Self-Examination | 1 | 2013 | 3 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2014 | 116 | 0.120 |
Why?
|
| Disease Management | 1 | 2015 | 114 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 219 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 1220 | 0.120 |
Why?
|
| Decision Making | 1 | 2015 | 220 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2012 | 67 | 0.110 |
Why?
|
| Female | 11 | 2017 | 16211 | 0.110 |
Why?
|
| Mass Screening | 1 | 2012 | 177 | 0.100 |
Why?
|
| Humans | 12 | 2017 | 29361 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2007 | 47 | 0.080 |
Why?
|
| Sentinel Surveillance | 2 | 2016 | 8 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2017 | 190 | 0.060 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 18 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 45 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 845 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 234 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 389 | 0.030 |
Why?
|
| Quality Control | 1 | 2013 | 43 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 840 | 0.030 |
Why?
|
| Patient Selection | 1 | 2013 | 232 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 770 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1829 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 2007 | 9 | 0.020 |
Why?
|
| Mastectomy, Segmental | 1 | 2007 | 13 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2007 | 113 | 0.020 |
Why?
|
| Adult | 2 | 2013 | 8604 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 175 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2007 | 159 | 0.020 |
Why?
|
| Middle Aged | 2 | 2013 | 9823 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 9447 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 3273 | 0.020 |
Why?
|
| Radiography | 1 | 2007 | 678 | 0.020 |
Why?
|
| Male | 1 | 2015 | 15637 | 0.010 |
Why?
|